|

Prospective Study Registry of Peripheral Neuroblastic Tumours Presenting With Spinal Canal Involvement (SCI)

RECRUITINGSponsored by Associazione Italiana Ematologia Oncologia Pediatrica
Actively Recruiting
SponsorAssociazione Italiana Ematologia Oncologia Pediatrica
Started2014-05
Est. completion2029-05
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02559804

Summary

To describe the natural history of peripheral neuroblastic tumour presenting with SCI and evaluate the combined effects of different risk factors on the eventual neurologic and orthopaedic outcomes

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Diagnosis of peripheral neuroblastic tumour - peripheral neuroblastic tumour (neuroblastoma, ganglioneuroblastoma, ganglioneuroma) presenting with SCI, symptomatic or asymptomatic, independent of disease extension (stage), and clinical course (first diagnosis or relapse/progression)
* No previous chemotherapy, except steroids, in the last 6 months
* Age \<18 years
* Minimal planned follow-up of 5 years
* Parent/patient written informed consent (Appendix 1(A,B,C))

Exclusion Criteria:

* Invasion of intervertebral foramina only

Conditions2

CancerNeuroblastic Tumors

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.